Reagents for Drug Toxicity Studies Using Megakaryocytes

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$80,998.00
Award Year:
1994
Program:
SBIR
Phase:
Phase I
Contract:
1 R43 CA63978-1,
Award Id:
24872
Agency Tracking Number:
24872
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
7581 Lindbergh Drive, Gaithersburg, MD, 20879
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
Ronald Brown
(301) 840-9331
Business Contact:
() -
Research Institute:
n/a
Abstract
The development of hematopoietic defined protein-free reagents that support megakaryocyteformation will be of inestimatable importance. The rationale for developing such reagents is that it willallow the measurement of drug toxicity in its unbound state in which all of the drug is active. Thereagents will be uniform standard reagents for such assays, save investigator time and effort indeveloping such reagents and facilitate drug evaluation free of bond drug. This research combinesthe strengths of two laboratories, one skilled in development of protein-free and serum-free reagentsand the other in megakaryocyte assay. Such a combination should bode well for the success of thisproposal. The Phase I effort will focus on the development of defined reagents for a murinemegakaryocyte assays. The Phase II effort will focus on the development of defined reagants forhuman megakaryocyte assays.

* information listed above is at the time of submission.

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government